From: Health care utilization at the end of life in Parkinson’s disease: a population-based register study
Variable | Univariable analysis. All patients, (n = 922) | Multivariable analysis. All patients, (n = 922) | Multivariable analysis, NH residents excluded, (n = 369) | |||
---|---|---|---|---|---|---|
ORa (95% CI) | p-value | aORb (95% CI) | p-value | aORb (95% CI) | p-value | |
Age groups | ||||||
18 – 74 years | Ref. | Ref. | Ref. | |||
75 – 79 years | 1.06 (0.71–1.56) | 0.78 | 1.02 (0.68–1.53) | 0.94 | 1.42 (0.74–2.73) | 0.30 |
≥80 years | 0.74 (0.53–1.03) | 0.08 | 0.74 (0.52–1.06) | 0.10 | 1.59 (0.90–2.82) | 0.11 |
Sex | ||||||
Women | Ref. | Ref. | Ref. | |||
Men | 1.39 (1.06–1.82) | 0.02 | 1.17 (0.88–1.56) | 0.27 | 0.91 (0.56–1.49) | 0.70 |
Socio-economic statusc | ||||||
Mosaic groups 1 + 2 | Ref. | Ref. | Ref. | |||
Mosaic group 3 | 0.92 (0.69–1.23) | 0.57 | 0.89 (0.66–1.21) | 0.46 | 1.23 (0.71–2.12) | 0.47 |
HFRSd | ||||||
1 (not frail) | Ref. | Ref. | Ref. | |||
2 + 3 (frail) | 3.97 (2.81–5.61) | < 0.0001 | 3.90 (2.75–5.55) | < 0.0001 | 2.86 (1.61–5.07) | 0.0003 |
SPC | ||||||
No | Ref. | Ref. | Ref. | |||
Yes | 1.11 (0.75–1.63) | 0.61 | 0.93 (0.62–1.38) | 0.72 | 0.36 (0.21–0.62) | 0.0002 |